Literature DB >> 29097824

An Efficient Synthesis of 4(5)-Benzyl-L-Histidines Employing Catalytic Transfer Hydrogenolysis at Elevated Temperatures.

D David Smith1, Audrey T Gallagher2, Vincent M Crowley2, Wayne M Gergens2, Peter W Abel3, Martin Hulce2.   

Abstract

An efficient two-step synthesis of 4(5)-benzyl-L-histidine from L-histidine was developed. A Pictet-Spengler reaction between L-histidine and benzaldehyde in the presence of excess strong base yielded 4-phenylspinacine within one hour. Catalytic transfer hydrogenolysis in methanol at reflux using ammonium formate rapidly converted 4-L-phenylspinacine to 4(5)-benzyl-L-histidine within five minutes. No racemization of the final product 4(5)-benzyl-L-histidine was observed using the Marfey reagent. To show the utility of this methodology, a series of fluorinated benzylhistidines is presented.

Entities:  

Keywords:  Pictet-Spengler reaction; amino acids; benzylation; catalytic transfer hydrogenolysis; electrophilic aromatic substitution

Year:  2013        PMID: 29097824      PMCID: PMC5663214          DOI: 10.1055/s-0033-1340462

Source DB:  PubMed          Journal:  Synthesis (Stuttg)        ISSN: 0039-7881            Impact factor:   3.157


  10 in total

Review 1.  International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors.

Authors:  David R Poyner; Patrick M Sexton; Ian Marshall; David M Smith; Remi Quirion; Walter Born; Roman Muff; Jan A Fischer; Steven M Foord
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

2.  Use of Marfey's reagent to quantitate racemization upon anchoring of amino acids to solid supports for peptide synthesis.

Authors:  J G Adamson; T Hoang; A Crivici; G A Lajoie
Journal:  Anal Biochem       Date:  1992-04       Impact factor: 3.365

3.  International Union of Pharmacology. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor.

Authors:  Debbie L Hay; David R Poyner; Remi Quirion
Journal:  Pharmacol Rev       Date:  2008-06-13       Impact factor: 25.468

4.  Pharmacological characterization of novel alpha-Calcitonin Gene-Related Peptide (CGRP) receptor peptide antagonists that are selective for human CGRP receptors.

Authors:  Christopher K Taylor; D David Smith; Martin Hulce; Peter W Abel
Journal:  J Pharmacol Exp Ther       Date:  2006-07-27       Impact factor: 4.030

5.  Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37).

Authors:  T Chiba; A Yamaguchi; T Yamatani; A Nakamura; T Morishita; T Inui; M Fukase; T Noda; T Fujita
Journal:  Am J Physiol       Date:  1989-02

6.  N-terminal bis-(2-chloroethyl)amino and fluorosulphonyl analogues of calcitonin gene-related peptide(8-37): irreversible antagonists at calcitonin gene-related peptide receptors.

Authors:  Christopher K Taylor; Peter W Abel; Martin Hulce; D David Smith
Journal:  Chem Biol Drug Des       Date:  2007-09       Impact factor: 2.817

7.  Potential histamine H2-receptor antagonists. 4. Benzylhistamines.

Authors:  J C Emmett; G J Durant; C R Ganellin; A M Roe; J L Turner
Journal:  J Med Chem       Date:  1982-10       Impact factor: 7.446

8.  Biomimetic approach to potential benzodiazepine receptor agonists and antagonists.

Authors:  F Guzman; M Cain; P Larscheid; T Hagen; J M Cook; M Schweri; P Skolnick; S M Paul
Journal:  J Med Chem       Date:  1984-05       Impact factor: 7.446

9.  Modifications to the N-terminus but not the C-terminus of calcitonin gene-related peptide(8-37) produce antagonists with increased affinity.

Authors:  D David Smith; Shankar Saha; Guoyong Fang; Courtney Schaffert; David J J Waugh; Wanyun Zeng; Geza Toth; Martin Hulce; Peter W Abel
Journal:  J Med Chem       Date:  2003-06-05       Impact factor: 7.446

Review 10.  Vascular actions of calcitonin gene-related peptide and adrenomedullin.

Authors:  Susan D Brain; Andrew D Grant
Journal:  Physiol Rev       Date:  2004-07       Impact factor: 37.312

  10 in total
  1 in total

1.  Using hyperpolarised NMR and DFT to rationalise the unexpected hydrogenation of quinazoline to 3,4-dihydroquinazoline.

Authors:  Josh E Richards; Alexander J J Hooper; Oliver W Bayfield; Martin C R Cockett; Gordon J Dear; A Jonathon Holmes; Richard O John; Ryan E Mewis; Natalie Pridmore; Andy D Roberts; Adrian C Whitwood; Simon B Duckett
Journal:  Chem Commun (Camb)       Date:  2018-09-11       Impact factor: 6.222

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.